568 related articles for article (PubMed ID: 24845475)
1. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
2. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
3. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient.
Asthana A; Chauhan AS; Diwan PV; Jain NK
AAPS PharmSciTech; 2005 Oct; 6(3):E536-42. PubMed ID: 16354015
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
6. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
7. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
8. PAMAM dendrimers for the delivery of the antibacterial Triclosan.
Gardiner J; Freeman S; Leach M; Green A; Alcock J; D'Emanuele A
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):623-8. PubMed ID: 18821252
[TBL] [Abstract][Full Text] [Related]
9. Polyamidoamine Dendrimers for Enhanced Solubility of Small Molecules and Other Desirable Properties for Site Specific Delivery: Insights from Experimental and Computational Studies.
Shadrack DM; Swai HS; Munissi JJE; Mubofu EB; Nyandoro SS
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895742
[TBL] [Abstract][Full Text] [Related]
10. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
Lu JJ; Wu ZH; Ping QN
Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693
[TBL] [Abstract][Full Text] [Related]
11. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
12. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
13. Solubility enhancement of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers.
Koç FE; Senel M
Int J Pharm; 2013 Jul; 451(1-2):18-22. PubMed ID: 23628406
[TBL] [Abstract][Full Text] [Related]
14. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
15. Polyamidoamine dendrimer decorated graphene oxide as a pH-sensitive nanocarrier for the delivery of hydrophobic anticancer drug quercetin: a remedy for breast cancer.
Matiyani M; Rana A; Pal M; Dokwal S; Sahoo NG
J Pharm Pharmacol; 2023 Jun; 75(6):859-872. PubMed ID: 37134308
[TBL] [Abstract][Full Text] [Related]
16. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.
Cheng Y; Man N; Xu T; Fu R; Wang X; Wang X; Wen L
J Pharm Sci; 2007 Mar; 96(3):595-602. PubMed ID: 17094130
[TBL] [Abstract][Full Text] [Related]
18. In vitro enzymatic stability of dendritic peptides.
Yang H; Lopina ST
J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of phenylbutazone and poly(amidoamine) dendrimers interactions by a combination of solubility, 2D-NOESY NMR, and isothermal titration calorimetry studies.
Yang W; Li Y; Cheng Y; Wu Q; Wen L; Xu T
J Pharm Sci; 2009 Mar; 98(3):1075-85. PubMed ID: 18680167
[TBL] [Abstract][Full Text] [Related]
20. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
